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a b s t r a c t
Intracerebroventricular (i.c.v.) injection of L- and D-aspartate (L- and D-Asp) has been shown to have a
sedative effect with and without a hypnotic effect, respectively, in neonatal chicks experiencing isolation
stress. However, the mechanisms of the different stress-attenuating functions of L- and D-Asp have not
yet been fully clarified. In the present study, we investigated the involvement of the N-methyl-D-
aspartate (NMDA) receptor in order to reveal the receptor-mediated function of L- and D-Asp. To reveal
whether L-and D-Asp act through the NMDA receptor, (þ)–MK-801, which is an antagonist of NMDA
receptors, was used in the current study. In experiment 1, the chicks were injected i.c.v. with either
saline, (þ)–MK-801, L-Asp or L-Asp plus (þ)–MK-801. The sedative and hypnotic effects induced by
L-Asp were blocked by co-administration with (þ)–MK-801. In experiment 2, the chicks were injected i.
c.v. with either saline, (þ)–MK-801, D-Asp or D-Asp plus (þ)–MK-801. Importantly, the sedative effects
induced by D-Asp were shifted to hypnotic effects by co-administration with (þ)–MK-801. Taken
together, L-Asp could induce sedative and hypnotic effects for stress behaviors through the NMDA
receptor, but the attenuation of stress behaviors by D-Asp might be via simultaneous involvement of
other receptors besides the NMDA receptor in this process. These differences may explain the different
functional mechanisms of L- and D-Asp in the central nervous system.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
It is well established that excitatory amino acids (EAAs),
L-glutamate (L-Glu) and L-aspartate (L-Asp) occur as neurotrans-
mitters in the chicken brain to act on the EAA receptors in the
central nervous system (CNS) (Balázs et al., 2012). These amino
acids can induce powerful stimulatory effects in the CNS
(Matthews et al., 1991). Most excitatory neurotransmission in the
brain is mediated by glutamate receptors, which are divided into
two groups: ionotropic and metabotropic glutamate receptors.
There are three classes of ionotropic receptor: N-methyl-D-aspar-
tate (NMDA); α-amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid (AMPA); and kainate (Cotman and Monaghan, 1989).
In previous studies it was shown that intracerebroventricular
(i.c.v.) administration of some L-amino acids caused sedative and
hypnotic effects through specific receptors under acutely stressful
conditions. For instance, L-proline (L-Pro) induced sedative and
hypnotic effects through the NMDA receptor (Hamasu et al., 2010),
but L-serine (Shigemi et al., 2008) and L-ornithine (Kurata et al.,
2011) acted through the γ-aminobutyric acid (GABA)A receptor.
The NMDA receptor is widely distributed in the CNS including the
hypothalamus (Halpain et al., 1984) and pituitary (Halpain et al.,
1984; Lindstrom̈ and Ohlsson, 1992), suggesting its involvement in
the neurotransmission process in the brain. It has been suggested
that in chicks, L-Asp may function through the NMDA receptor
(Chen et al., 2005) as a selective NMDA receptor agonist (Kubrusly
et al., 1998). Recently, it was reported that i.c.v. administration of
(þ)–MK-801, an NMDA receptor antagonist, stimulated distress
vocalizations (DVs) and active wakefulness and decreased sitting
or standing time in chicks treated with i.c.v. L-Pro (Hamasu et al.,
2010).
D-Asp, a metabolite of L-Asp, is also present in the nervous
tissues of chickens (Neidle and Dunlop, 1990). Although there have
been a considerable number of investigations into the function of
D-Asp regarding its role in the endocrine system (D'Aniello, 2007),
in food intake (Koyuncuoğlu et al., 1982; Erwan et al., 2013a,b) and
in thermoregulation (Koyuncuoğlu and Berkman, 1982), there has
been less exploration of its role as a possible neurotransmitter.
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Both L- and D-Asp induced sedative effects under an acutely
stressful condition. However, L-Asp, but not D-Asp, increased the
time spent in a sleeping posture (Erwan et al., 2012).
Using neonatal chicks, Feltenstein et al. (2003) investigated the
behaviors induced by social-isolation stress. When chicks are
isolated, they express characteristic stress-related behaviors which
include increased DVs, active wakefulness, and a decrease in
sleeping behavior (Yamane et al., 2009b). These stressful beha-
vioral parameters were taken as a standard against which to assess
the anxiolytic activity of several amino acids (Shigemi et al., 2008;
Kurata et al., 2011; Erwan et al., 2012). Therefore, observation of
these behaviors resulting from isolation stress together with L-and
D-Asp treatments can be useful for estimating the anti-anxiety
effects of these amino acids.
We looked at all these findings together, to clarify the differ-
ence in function between L- and D-Asp in terms of decreasing
stress behavior, and hypothesized that the NMDA receptor may
be involved in the stress-attenuating process which could
be identified in chicks by using the NMDA receptor antagonist,
(þ)–MK-801.
2. Material and methods
2.1. Animals and drugs
One-day-old layer chicks were purchased from a local hatchery
(Murata hatchery, Fukuoka, Japan) and housed in a wire-meshed
cage (503533 cm3) in a group (20–25 birds) at a constant
temperature of 30711C and with continuous light until the
experimental day. Chicks were all of the same age and were
housed without an adult. Food (AX, Toyohashi Feed and Mills Co.
Ltd., Aichi, Japan) and water were available ad libitum. On the day
of the experiment, chicks (5–6 days old) were assigned to treat-
ment groups on the basis of their body weight in order to produce
uniform treatment groups. The number of animals used in each
group was kept to the minimum that would still ensure adequate
statistical power. This study was performed according to the
Guidance for animal experiments in the faculty of agriculture
and in the graduate course of Kyushu University and Law No. 105
and Notification No. 6 of the government. L- and D-Asp were
purchased from Wako Pure Chemical Industries (Osaka, Japan).
The NMDA receptor antagonist (þ)–MK-801 maleate was pur-
chased from Tocris Bioscience (Ellisville, USA). The drugs were
dissolved in a vehicle of 0.85% saline containing 0.1% Evans Blue
(Wako Pure Chemical Industries, Ltd., Osaka, Japan).
2.2. Procedure for behavioral test
Drugs were injected intracerebroventricularly (i.c.v.) by micro-
syringe into the left lateral ventricle of the chicks in a 10-μl dose,
using the method of Davis et al. (1979). Minimal stress and pain
are experienced when this method is used, as described elsewhere
(Koutoku et al., 2005). Each chick received a single injection in line
with any one of the treatments described below. As for the dose, in
the current study, based on our previous report (Erwan et al.,
2012), we decided to use 1.68 μmol of L- or D-Asp to analyze the
mechanism of attenuating stress responses. Recently, we reported
that of different doses of L- and D-Asp (0.42, 0.84 or 1.68 μmol), only
the highest dose completely attenuated the responsiveness of chicks
experiencing isolation-induced stress compared with the control.
Although the low and medium doses showed a dose-dependent
tendency of declining stress behavior, no significant effect was
found (Erwan et al., 2012). In Experiment 1, chicks were adminis-
tered either vehicle saline, (þ)–MK-801 maleate (0.50 nmol), L-Asp
(1.68 mmol) or L-Asp (1.68 mmol) plus (þ)–MK-801 maleate
(0.50 nmol). Experiment 2 was similar to experiment 1 except L-
Asp was replaced with D-Asp. The dosage of (þ)–MK-801 was
based on that specified in a previous study (Hamasu et al., 2010).
After injection, chicks were immediately placed in a monitoring
cage (40 cm30 cm20 cm acrylic glass) with paper (changed for
each animal) on the floor. Video cameras were positioned to record
on digital versatile disc (DVD) the behavior of chicks from three
different directions. The postures recorded during a 10-min period
were characterized as (1) active wakefulness; (2) standing/sitting
motionless with eyes open; (3) standing motionless with eyes
closed; and (4) sitting motionless with head drooped (sleeping
posture). The sedative effect was evaluated by categories (1), (2),
and (3), whereas the hypnotic effect was evaluated by category (4)
(Suenaga et al., 2008). It was found in young adult hens that with
both the sleeping posture (head tucked under a wing) and the
resting posture with eyes closed, electrophysiological sleep nearly
always occurred (van Luijtelaar et al., 1987). The time each chick
spent in each posture was determined by watching the DVDs.
During the monitoring period, chicks were deprived of water and
food. DVs of the chicks were simultaneously recorded and counted
using Gretchen software (Excla Inc., Japan), and suppression of DVs
was judged as a sedative effect. Data were collected each second for
the 10-min period. The monitoring systems were in a separate room
to avoid disturbing the animals. At the end of the experiments, the
birds were decapitated following anesthesia with isoflurane (Mylan
Inc., Japan).
2.3. Statistical analysis
In all the experiments, data were statistically analyzed by a
randomized two-way analysis of variance (ANOVA), and the
Tukey–Kramer test was done as a post hoc test when a significant
interaction was detected. Significant differences implied Po0.05.
Values are presented as means7S.E.M. Statistical analysis was
conducted using a commercially available package, StatView (ver-
sion 5, SAS Institute, Cary, USA, 1998). All data were first subjected
to a Thompson rejection test to eliminate outliers (Po0.01), and
the data that remained were used in the analysis among groups.
3. Results
3.1. Effects of (þ)–MK-801 on sedative and hypnotic behaviors
induced by L-Asp
Fig. 1 shows the effects of i.c.v. injection of L-Asp with or
without (þ)–MK-801 on the number of DVs, a measure of social
separation stress, for 10 min post injection. Significant sedative
effects of L-Asp (F[1, 19]¼14.65, Po0.005) and (þ)–MK-801 (F[1,
19]¼4.74, Po0.05) were detected. An interaction between L-Asp
and (þ)–MK-801 was significant (F[1, 19]¼ 5.58, Po0.05), sug-
gesting that the suppressive effect of L-Asp on DVs was attenuated
by the co-injection of (þ)–MK-801.
Table 1 shows the effect of i.c.v. injection of L-Asp with or
without (þ)–MK-801 on chicks undergoing social-isolation stress
during the 10-min behavioral observation period in terms of
various behavioral categories. Significant effects of L-Asp (F[1, 19]¼
34.00, Po0.0001) and (þ)–MK-801 (F[1, 19]¼7.00, Po0.05) were
detected on active wakefulness. L-Asp also showed significant effect
(F[1, 19]¼9.95, Po0.01) on standing/sitting motionless with eyes
open. In addition, significant effects of L-Asp (F[1, 19]¼16.06,
Po0.001) and (þ)–MK-801 (F[1, 19]¼8.74, Po0.01) on sitting
motionless with head drooped (sleeping posture) were detected.
Interactions between L-Asp and (þ)–MK-801 were significant in the
following categories: active wakefulness (F[1,19]¼7.43, Po0.05);
and sitting motionless with head drooped (sleeping posture)
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(F[1,19]¼6.49, Po0.05) - representing the sedative effect and the
hypnotic effect, respectively. L-Asp increased sitting motionless
with head drooped (the sleeping posture) and decreased active
wakefulness, and (þ)–MK-801 attenuated these effects. Since (þ)–
MK-801 did not affect the behavioral categories under the control
conditions, these results indicate that (þ)–MK-801 altered beha-
viors induced by L-Asp. The sleeping posture induced by L-Asp was
attenuated by co-injection with (þ)–MK-801, and consequently the
behavior of chicks tended toward wakefulness.
3.2. Effects of (þ)–MK-801 on sedative and hypnotic behaviors
induced by D‐Asp
Fig. 2 shows the effects of i.c.v. injection of D-Asp with or
without (þ)–MK-801 on the number of DVs for 10 min post-
injection. A significant effect of D-Asp (F[1, 18]¼ 48.14, Po0.0001)
was detected, but no significant effect was observed with (þ)–MK-
801 (F[1, 18]¼ 1.09, P40.05). The lack of a significant (F[1, 18]¼
1.09, P40.05) interaction between D-Asp and (þ)–MK-801 implies
that the effect of D-Asp was not attenuated by (þ)–MK-801.
Table 2 shows the effect of i.c.v. injection of D-Asp with or
without (þ)–MK-801 on chicks experiencing social-isolation
stress during the 10-min behavioral observation period in terms
of various behavioral categories. D-Asp showed significant effect
on active wakefulness (F[1, 19]¼28.62, Po0.0001) and standing/
sitting motionless with eyes open (F[1, 19]¼5.07, Po0.05). In
addition, significant effects of D-Asp (F[1, 19]¼28.81, Po0.0001)
and (þ)–MK-801 (F[1, 19]¼6.23, Po0.05) on sitting motionless
with head drooped (sleeping posture) were detected. Interactions
between D-Asp and (þ)–MK-801 were significant in the following
categories: standing/sitting motionless with eyes open (F[1, 19]¼
6.35, Po0.05); and sitting motionless with head drooped (sleep-
ing posture) (F[1, 19]¼ 7.97, Po0.05). These results indicate that
(þ)–MK-801 altered behaviors induced by D-Asp. Co-injection of
D-Asp and (þ)–MK-801 partially attenuated standing/sitting
motionless with eyes open and, interestingly, induced the sleeping
posture, a hypnotic behavior.
4. Discussion
We confirmed that i.c.v. injection of L-Asp can attenuate the
stress responses under an acutely stressful isolation condition
(Fig. 1, Table 1). L-Asp is most likely a neurotransmitter that
mimics the actions of L-Glu (Kubrusly et al., 1998). Recently, our
laboratory found that i.c.v. administration of L-Glu attenuated total
DVs and induced sedation in chicks (Yamane et al., 2009b). L-Asp
caused sedative and hypnotic effects under acutely stressful social-
isolation conditions with or without i.c.v. injection of corticotrophin-
releasing factor (CRF) (Yamane et al., 2009a; Erwan et al., 2012).
It was further reported that the amount of L-Asp decreased in the
diencephalon of neonatal chicks exposed to both restraint with
isolation and fasting stress, indicating that L-Asp may be related to
the stress response (Hamasu et al., 2009). L-Asp appears to act as a
selective NMDA receptor agonist in chicks (Kubrusly et al., 1998) and
mammals (Patneau and Mayer, 1990). In terms of the mechanism
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Fig. 1. Effects of i.c.v. injection of saline, (þ)–MK-801 maleate (0.50 nmol), L-Asp
(1.68 mmol) or L-Asp (1.68 mmol) plus (þ)–MK-801 maleate (0.50 nmol) on total
number of distress vocalizations during 10 min of isolation in 5–6-day-old layer
chicks (n¼ 5 or 6). Results are expressed as means7S.E.M. nSignificantly different
from other treatments at Po0.05.
Table 1
Effects of i.c.v. injection of (þ)–MK-801 and L-aspartate on various behavioral categories of chicks exposed to social separation stress for 10 min.
Saline L-Aspartate P
(þ)–MK-801  þ  þ L-Aspartate (þ)–MK-801 L-Aspartate  (þ)–MK-801
Active wakefulness 458745b 454770b 47714a 304753b o0.0001 o0.05 o0.05
Standing/sitting motionless with eyes open 111737 129759 295738 228746 o0.01 NS NS
Standing motionless with eyes closed 070 070 070 070 NS NS NS
Sitting motionless with head drooped (sleeping posture) 31721b 17717b 258747a 68739b o0.001 o0.01 o0.05
Total (s) 600 600 600 600
Values are mean7S.E.M. in seconds. The number of chicks used in each group was as follows: saline, 6; (þ)–MK-801, 5; L-Asp, 6; and L-Asp (1.68 mmol) plus (þ)–MK-801, 6.
NS, not significant. Means with different superscripts are significantly different at Po 0.05.
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Fig. 2. Effects of i.c.v. injection of saline, (þ)–MK-801 maleate (0.50 nmol), D-Asp
(1.68 mmol) or D-Asp (1.68 mmol) plus (þ)–MK-801 maleate (0.50 nmol) on total
number of distress vocalizations during 10 min of isolation in 5–6-day-old layer
chicks (n¼ 5 or 6). Results are expressed as means7S.E.M.
E. Erwan et al. / European Journal of Pharmacology 736 (2014) 138–142140
involved, in the current study we revealed that the sedative and
hypnotic effects of L-Asp are mediated via the NMDA receptor since
the sedative and hypnotic effects induced by L-Asp were negated by
its antagonist, (þ)–MK-801. The i.c.v. injection of 0.5 nmol of MK-801
alone did not influence isolation stress-induced behaviors. These
results indicate that the NMDA receptor is involved in sedative and
hypnotic effects induced by L-Asp.
Many findings have indicated that D-amino acids may act as a
putative neuromodulator or neurotransmitter (Schell et al., 1997;
Errico et al., 2008a, b). In the current study, it was confirmed that
i.c.v. injection of D-Asp could attenuate the stress response
induced by isolation stress. The mechanism of the sedative effect
of D-Asp was further revealed in neonatal chicks. It was clearly
observed that i.c.v. injection of D-Asp strongly decreased DVs and
active wakefulness (Fig. 2, Table 2). In addition, in comparison with
the control group, D-Asp increased the amount of time spent
standing/sitting motionless with eyes open. This finding is also
consistent with our previous report (Erwan et al., 2012). It was
further found that co-injection of D-Asp with (þ)–MK-801 did not
totally revive the DVs that were attenuated by the D-Asp (Fig. 2).
This was the case also for the active wakefulness behavior: the
active wakefulness that was decreased by administration of D-Asp
was not restored when D-Asp was co-injected with (þ)–MK-801.
However, the amount of time spent standing/sitting motionless
with eyes open was reduced when D-Asp was co-injected with
(þ)–MK-801. These results suggest that some stress-attenuating
functions of D-Asp may occur through other receptor(s) besides
the NMDA receptor. Until recently, the selective receptor for D-Asp
had not been precisely identified (Carlson and Fieber, 2011; Ota
et al., 2012). Although D-Asp is presumed to be activated as a
subset of the L-Glu channels, the identities of the putative D-Asp
receptors and channels are unclear (Carlson and Fieber, 2011).
It has been reported that D-Asp activated the same receptor that
L-Glu did, but D-Asp also activated other receptors in many cells
which were not responding to L-Glu (Carlson et al., 2012).
Furthermore, D-Asp is a well-known activator of the NMDA
receptor, but conceivably D-Asp may also act as a neurotransmitter
for other receptors (Gong et al., 2005; Brown et al., 2007; Carlson
and Fieber, 2011). Hamasu et al. (2010) showed that L-and D-Pro
differentially induced sedative and hypnotic effects through the
NMDA receptor and the glycine receptor, respectively. Thus, the
two isomers of Asp may activate different receptors to induce its
function of attenuating stress. Interestingly, hypnotic effects were
strongly induced by the combination of D-Asp and (þ)–MK-801. In
blocking the NMDA receptor, D-Asp showed a similar effect to that
of L-Asp itself. This may be through unidentified receptors stimu-
lated by D-Asp. This possibility should to be clarified in future
studies.
It has further been reported that the metabotropic glutamate
(mGlu) receptor 5 is linked to the NMDA receptor (Tu et al., 1999),
supporting the interaction between these two receptor types
(Awad et al., 2000; Pisani et al., 2001). Molinaro et al. (2010)
suggested that D-Asp, but not L-Asp, activated the mGlu receptor
5 in the early postnatal rat brain. The mGlu receptor 5 could play
various roles in the stress response because stress-induced
hyperthermia was reduced in mGlu receptor 5 knockout mice
(Brodkin et al., 2002). Furthermore, it was reported that the mGlu
receptor 5 was involved in stress responsiveness in mammals
(Brodkin et al., 2002). Matosin and Newell (2013) described that
the mGlu receptor 5 was altered in response to NMDA receptor
antagonist treatment in adult rats. Thus, we could speculate that in
the current study, a possible alteration in the coupling between
the NMDA receptor and the mGlu receptor 5 may have occurred
when the NMDA receptor blocker, MK-801, was used to induce
hypnotic behavior in chicks. These facts indicate that D-Asp may
act through the NMDA receptor, including the mGlu receptor 5, to
induce the anti-stress function. On the other hand, kynurenic acid,
one of the tryptophan metabolites in the kynurenine pathway,
functioned via the simultaneous inhibition of the NMDA receptor
subgroup and the α7 nicotinic acetylcholine receptor (Yoshida
et al., 2013). It is possible that D-Asp simultaneously induces
NMDA receptor and other receptors. Further research is needed to
clarify the possible mechanism of the D-Asp function in chicks.
5. Conclusions
In conclusion, i.c.v. administration of both L- and D-Asp
induced sedative effects under an acutely stressful condition. The
mechanism of the attenuation of the acute stress response by
L-Asp is mediated through the NMDA receptor in the CNS, while
D-Asp may be involved with other receptors besides the NMDA
receptor in attenuating stress behaviors in chicks. Overall, our data
imply important roles of L- and D-Asp in reducing stress behavior
in chicks which may lead to important benefits in interdisciplinary
study.
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